Mounjaro (Tirzepatide) Injection

The newest dual-action weight loss injection

Mounjaro (tirzepatide) acts on both GLP-1 and GIP receptors simultaneously, making it the most effective injectable weight loss medication currently approved. Clinical trials showed average weight loss of 20–22% of body weight — more than any previous injectable therapy. Available at Enfield Royal Clinic Khalifa City under full medical supervision.

Tirzepatide was first approved for type 2 diabetes (Mounjaro) and subsequently for chronic weight management (Zepbound/Mounjaro). It mimics two gut hormones that regulate appetite and blood sugar, reducing hunger significantly while improving metabolic function. Weekly self-injection with automatic dose escalation over the programme period.

Key Benefits

Dual GLP-1/GIP mechanism — more effective than semaglutide alone
Average 20–22% body weight loss in clinical trials
Weekly injection — one pen per week
Improves blood sugar, blood pressure and lipid profile alongside weight

Is This Treatment Right For You?

Adults with a BMI of 30+ or 27+ with a weight-related condition
Patients who have tried Ozempic or Wegovy with limited results
Those with type 2 diabetes seeking combined metabolic and weight benefits

What to Expect

Medical Screening

Full health review: BMI, blood tests, metabolic panel, thyroid screening.

Prescription

Mounjaro prescribed at starting dose (2.5mg); auto-pen demonstrated.

Dose Escalation

Dose increased every 4 weeks (2.5 → 5 → 7.5 → 10 → 12.5 → 15mg) based on tolerance.

Monitoring

Monthly check-ins; blood tests at 3 and 6 months to monitor metabolic markers.

Recovery & Aftercare

No downtime; mild nausea or GI discomfort is common in the first 1–2 weeks at each new dose.

Frequently Asked Questions

How much does Mounjaro cost in Abu Dhabi?

Mounjaro medication costs approximately AED 900–1,400 per monthly supply depending on dose. The medical consultation and monitoring programme is priced separately. A full quote is provided at your consultation.

Is Mounjaro better than Ozempic for weight loss?

Clinical trial data shows tirzepatide (Mounjaro) produces greater average weight loss than semaglutide (Ozempic/Wegovy) at maximum doses — approximately 20–22% vs 15% of body weight. Individual results vary.